Trial reportJournal of medical Internet research2014
Impact of patient access to Internet health records on glaucoma medication: randomized controlled trial.
Trial report in Journal of medical Internet research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 4 syntheses or guidelines pooled it, 13 citations in OpenAlex.
- Adult patient access to electronic health records.The Cochrane database of systematic reviews · 2021Pooled it
- Impact of providing patients access to electronic health records on quality and safety of care: a systematic review and meta-analysis.BMJ quality & safety · 2020Pooled it
- Patient and provider attitudes toward the use of patient portals for the management of chronic disease: a systematic review.Journal of medical Internet research · 2015Pooled it
- The effect of patient portals on quality outcomes and its implications to meaningful use: a systematic review.Journal of medical Internet research · 2015Pooled it
- A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan.International ophthalmology · 2019Article
- Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy.Patient preference and adherence · 2018Article
- Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma.BMC ophthalmology · 2017Observational
- Electronic medical record and glaucoma medications: connecting the medication reconciliation with adherence.Clinical ophthalmology (Auckland, N.Z.) · 2016Article
- Performance of popular large language models in glaucoma patient education: A randomized controlled study.Advances in ophthalmology practice and researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlaucoma is one of the leading causes of blindness. Reduction of intraocular pressure is the only proven way to prevent progression of glaucomatous optic neuropathy. The majority of glaucoma patients need to use antiglaucoma ophthalmic solutions over the course of their life. Thus, good adherence and persistency of glaucoma treatment are important factors for better glaucoma care.
objectiveThe purpose of this study was to investigate the impact of an Internet-based glaucoma care support system on glaucoma medication use.
methodsPatients were randomly divided into two groups. The non-Internet access (NIA) group consisted of patients who had access to the Internet-based glaucoma care support system during the 4-year period only when they were examined by ophthalmologists. The Internet access (IA) group consisted of patients who had the same Internet-based glaucoma care support system access as the NIA group for the first 2 years following enrollment but who were also given free access to the glaucoma care support system for the remaining 2 years. Changes in glaucoma medication use were investigated.
resultsIn total, 81 patients in the IA group and 90 patients in the NIA group satisfied the study protocol. The number of antiglaucoma ophthalmic solutions used during the study period significantly increased in the NIA group (P<.03) but not in the IA group. The percentages of patients with unchanged, increased, and decreased antiglaucoma ophthalmic solution use during the study period were 61.1% (55/90), 17.8% (16/90), and 3.3% (3/90), respectively, in the NIA group, and 56.8% (46/81), 8.6% (7/81), and 13.6% (11/81), respectively, in the IA group (P<.001). Internet access significantly shifted from an increasing intraocular pressure trend to a decreasing trend in the IA group (P=.002) among the patients who did not have any medication changes.
conclusionsAllowing patients to browse their medical data may reduce the use and improve the effectiveness of glaucoma medication.
trial registrationUMIN-CTR Clinical Trial Number: UMIN000006982; https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000008238&language=E (Archived by WebCite at http://www.webcitation.org/6MRPQeEAv).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.